NCT04729023

Brief Summary

Pars plana vitrectomy (PPV) is one of the most widely used surgical therapies to proliferative diabetic retinopathy in the world. However, as a predictable consequence of PPV surgery, postoperative cataract is observed in 79%-95% of phakic diabetes retinopathy patients after PPV in 6-24 months and a subsequent cataract surgery is usually required. While, the subsequent cataract surgeries not only bring additional economy and workload burden, but also increase the surgical risks. Since the two-step surgical approach has its defects, the combination of PPV and phacoemulsification is an ideal surgical option. This study is a multi-center prospective study, aimed to evaluate the effect of PPV combined with phacoemulsification cataract surgery in phakic diabetes retinopathy patients, and make a comparation between the combined surgery and the two-step surgery in patients without severe lens opacities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
129

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 28, 2021

Completed
4 days until next milestone

Study Start

First participant enrolled

February 1, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 2, 2022

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 5, 2022

Completed
Last Updated

September 9, 2022

Status Verified

September 1, 2022

Enrollment Period

1.6 years

First QC Date

January 21, 2021

Last Update Submit

September 8, 2022

Conditions

Keywords

Diabetic RetinopathyDiabetic CataractPars plana vitrectomyPhacoemulsification

Outcome Measures

Primary Outcomes (4)

  • Best correct visual acuity (BCVA)

    BCVA with early treatment diabetic retinopathy study (ETDRS) letters

    Change from Baseline at 1 week after the surgery(s)

  • Best correct visual acuity

    BCVA with ETDRS letters

    Change from Baseline at 1 month after the surgery(s)

  • Best correct visual acuity

    BCVA with ETDRS letters

    Change from Baseline at 3 months after the surgery(s)

  • Best correct visual acuity

    BCVA with ETDRS letters

    Change from Baseline at 6 months after the surgery(s)

Secondary Outcomes (4)

  • VFQ-25 score

    Change from Baseline at 6 months after the surgery(s).

  • Complications

    through study completion, an average of 1 year

  • Treatment costs

    through study completion, an average of 1 year

  • Working delay time

    through study completion, an average of 1 year

Study Arms (2)

Combined surgery group

EXPERIMENTAL

In this group, all eligible patients will receive pars plana vitrectomy combined with phacoemulsification cataract surgery.

Procedure: Pars plana vitrectomy combined with cataract surgery.

Subsequent surgery group

ACTIVE COMPARATOR

In this group, all eligible patients will receive pars plana vitrectomy first. And a subsequent phacoemulsification will be systematically performed 6 months after the PPV surgery.

Procedure: Pars plana vitrectomy with subsequent cataract surgery.

Interventions

In the combined surgery group, phakic diabetes retinopathy patients over 45 years old without severe lens opacity will receive pars plana vitrectomy combined with phacoemulsification and intraocular lens (IOL) implantation at the same time.

Combined surgery group

In the control group, phakic diabetes retinopathy patients over 45 years old without severe lens opacity will first receive pars plana vitrectomy and a subsequent phacoemulsification with IOL implantation will be performed at least 6 month after the PPV.

Subsequent surgery group

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Proliferative diabetes retinopathy ;
  • Age over 45 years old;
  • mild-moderate lens opacities(LOCSⅢ : C3N3P3 or below);
  • recognition of at least one alphabet in ETDRS chart.

You may not qualify if:

  • Long-standing retinal detachment (more than three months), macular affected
  • Low Vision or blind on the other eye;
  • Macular degeneration, including age-related macular degeneration and Polypoidal choroidal vasculopathy;
  • Ocular trauma;
  • Glaucoma;
  • Hereditary retinopathy;
  • Severe lens opacities before the surgery (LOCSⅢ : C4N4P4 or above).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Ophthalmic center, Sun Yat-sen University

Guangzhou, Guangdong, 550000, China

Location

Related Publications (13)

  • Novak MA, Rice TA, Michels RG, Auer C. The crystalline lens after vitrectomy for diabetic retinopathy. Ophthalmology. 1984 Dec;91(12):1480-4. doi: 10.1016/s0161-6420(84)34100-8.

    PMID: 6521988BACKGROUND
  • Hsuan JD, Brown NA, Bron AJ, Patel CK, Rosen PH. Posterior subcapsular and nuclear cataract after vitrectomy. J Cataract Refract Surg. 2001 Mar;27(3):437-44. doi: 10.1016/s0886-3350(00)00585-x.

    PMID: 11255058BACKGROUND
  • Melberg NS, Thomas MA. Nuclear sclerotic cataract after vitrectomy in patients younger than 50 years of age. Ophthalmology. 1995 Oct;102(10):1466-71. doi: 10.1016/s0161-6420(95)30844-5.

    PMID: 9097793BACKGROUND
  • Blodi BA, Paluska SA. Cataract after vitrectomy in young patients. Ophthalmology. 1997 Jul;104(7):1092-5. doi: 10.1016/s0161-6420(97)30180-8.

    PMID: 9224458BACKGROUND
  • Westesson PL, Lundh H. Temporomandibular joint disk displacement: arthrographic and tomographic follow-up after 6 months' treatment with disk-repositioning onlays. Oral Surg Oral Med Oral Pathol. 1988 Sep;66(3):271-8. doi: 10.1016/0030-4220(88)90230-7.

    PMID: 3174063BACKGROUND
  • Soto-Hernandez JL, Nunley D, Gutierrez CC, Berk SL. Listeria monocytogenes peritonitis. Am J Gastroenterol. 1988 Feb;83(2):180-2.

    PMID: 3341344BACKGROUND
  • Peyman GA, Huamonte F, Goldberg MF. Management of cataract in patients undergoing vitrectomy. Am J Ophthalmol. 1975 Jul;80(1):30-6. doi: 10.1016/0002-9394(75)90864-8.

    PMID: 1155546BACKGROUND
  • Treumer F, Bunse A, Rudolf M, Roider J. Pars plana vitrectomy, phacoemulsification and intraocular lens implantation. Comparison of clinical complications in a combined versus two-step surgical approach. Graefes Arch Clin Exp Ophthalmol. 2006 Jul;244(7):808-15. doi: 10.1007/s00417-005-0146-9. Epub 2005 Dec 3.

    PMID: 16328429BACKGROUND
  • Biro Z, Kovacs B. Results of cataract surgery in previously vitrectomized eyes. J Cataract Refract Surg. 2002 Jun;28(6):1003-6. doi: 10.1016/s0886-3350(02)01237-3.

    PMID: 12036644BACKGROUND
  • Meyers SM, Klein R, Chandra S, Myers FL. Unplanned extracapsular cataract extraction in postvitrectomy eyes. Am J Ophthalmol. 1978 Nov;86(5):624-6. doi: 10.1016/0002-9394(78)90179-4.

    PMID: 309730BACKGROUND
  • Smiddy WE, Stark WJ, Michels RG, Maumenee AE, Terry AC, Glaser BM. Cataract extraction after vitrectomy. Ophthalmology. 1987 May;94(5):483-7. doi: 10.1016/s0161-6420(87)33420-7.

    PMID: 3601363BACKGROUND
  • Senn P, Schipper I, Perren B. Combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in the capsular bag: a comparison to vitrectomy and subsequent cataract surgery as a two-step procedure. Ophthalmic Surg Lasers. 1995 Sep-Oct;26(5):420-8.

    PMID: 8963856BACKGROUND
  • Silva PS, Diala PA, Hamam RN, Arrigg PG, Shah ST, Murtha TL, Schlossman DK, Cavallerano JD, Sun JK, Aiello LP. Visual outcomes from pars plana vitrectomy versus combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in patients with diabetes. Retina. 2014 Oct;34(10):1960-8. doi: 10.1097/IAE.0000000000000171.

    PMID: 24830822BACKGROUND

MeSH Terms

Conditions

Diabetic Retinopathy

Interventions

Cataract Extraction

Condition Hierarchy (Ancestors)

Retinal DiseasesEye DiseasesDiabetic AngiopathiesVascular DiseasesCardiovascular DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Refractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 21, 2021

First Posted

January 28, 2021

Study Start

February 1, 2021

Primary Completion

September 2, 2022

Study Completion

September 5, 2022

Last Updated

September 9, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations